[Form 4] eXp World Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Scotts Miracle-Gro (SMG) – Form 144 filing: An affiliate plans to sell up to 70,000 common shares, equal to roughly 0.12% of the 57.7 million shares outstanding. The proposed sale, valued at about $4.35 million, is to be executed through Merrill Lynch on the NYSE around 04 Aug 2025.

The shares were originally obtained on 16 Jun 1995 via a partnership contribution. No shares have been sold by the filer in the last three months. The filer certifies that no undisclosed material adverse information is known.

Because the notice covers secondary stock already in issue, there is no dilution to existing holders. However, the transaction may signal the holder’s desire to reduce exposure; investors may watch forthcoming Form 4s for additional insider activity.

Positive

• No dilution: shares already outstanding; capital structure unchanged.
• Regulatory transparency: timely Rule 144 notice shows adherence to insider-sale disclosure rules.

Negative

• Potential negative signal: insider disposing of $4.35 m in stock could be interpreted as reduced confidence.
• Unidentified seller: absence of identity limits ability to gauge strategic importance of the sale.

Insights

Financial Analyst

TL;DR – Modest insider sale; minor impact given 0.12 % of shares.

70 k shares worth $4.35 m represent a small fraction of SMG’s float. The sale will not alter share count or capital structure, but insider selling can sometimes precede price weakness if viewed as a negative signal. Absent context on the seller’s role or broader selling patterns, I view the filing as informational rather than catalytic.

Corporate Governance Expert

TL;DR – Insider liquidity event; governance risk minimal.

The Form 144 indicates compliance with Rule 144 disclosure. Lack of recent sales and the small percentage suggest routine diversification. Still, continuous monitoring of subsequent filings is prudent to detect any accelerated insider exit that might raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Weakley Monica

(Last) (First) (Middle)

C/O EXP WORLD HOLDINGS, INC.

2219 RIMLAND DRIVE, SUITE 301

(Street)

BELLINGHAM WA 98226

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
eXp World Holdings, Inc. [ EXPI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2025		A		321(1)	A	$8.65	8,794	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock	$0.00(2)	07/31/2025		A		44		(3)	(4)	Common Stock	44	$0.00	550	D
Common Stock	$0.00(2)	07/31/2025		A		796		(5)	(4)	Common Stock	796	$0.00	1,346	D

Explanation of Responses:

1. These shares were issued to the reporting person under eXp World Holdings, Inc.'s (the "Issuer") Agent Equity Program.

2. Represents a grant of RSUs awarded under the Issuer's Agent Growth Incentive Program, administered under the 2024 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.

3. The RSUs are scheduled to vest 100% on June 30, 2028, subject to the reporting person's continued service to the Issuer through the respective vesting date.

4. RSUs do not expire; they either vest or are canceled prior to the vesting date.

5. The RSUs are scheduled to vest 100% on July 15, 2028, subject to the reporting person's continued service to the Issuer through the respective vesting date.

Remarks:

	/s/ James Bramble, attorney-in-fact for Monica Weakley	08/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Scotts Miracle-Gro shares are being registered for sale?

Up to 70,000 common shares are covered by this Form 144.

What is the estimated market value of the shares?

The aggregate value stated in the filing is approximately $4.35 million.

When is the planned sale date for SMG stock?

The filer lists an approximate sale date of 04 Aug 2025.

Will this insider sale dilute existing SMG shareholders?

No. The notice relates to resale of already-issued shares, so share count is unaffected.

Where will the shares be sold and through which broker?

Sales are planned on the NYSE via Merrill Lynch, 8890 Lyra Dr, Columbus OH.

When were the shares originally acquired?

They were acquired on 16 Jun 1995 through a partnership contribution.